March 2012 Michael Cobble, MD Chief Medical Officer Effects of coadministered extended-release niacin laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. Christie Ballantyne, MD, et al. J - Cobble - Document - PDFSEARCH.IO

First Page	Meta Content
	March 2012 Michael Cobble, MD Chief Medical Officer Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. Christie Ballantyne, MD, et al. J Add to Reading List Document Date: 2012-03-22 16:47:40 Open Document File Size: 101,59 KB Share Result on Facebook Facility National Institute of Health News / / MedicalCondition niacin-induced flushing / dyslipidemia / hypercholesterolemia / flushing / / MedicalTreatment statin therapy / / Organization National Institute of Health / / Person Christie Ballantyne / Michael Cobble / / Position Chief Medical Officer / / Product Laropiprant / simvastatin / niacin / / Technology use VAP DGU technology / / URL http / SocialTag Cardiology Lipoproteins Nutrition Steroids Sterols Low-density lipoprotein Vertical Auto Profile Statin Hypercholesterolemia Chemistry

March 2012 Michael Cobble, MD Chief Medical Officer Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. Christie Ballantyne, MD, et al. JAdd to Reading List